Project Grant R01GM153752

Award Date 9/1/24
Completion Date 6/30/29
Dollars Obligated $578K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This Project Grant award in the amount of $148,568.00 was issued by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The award aims to identify the developmental mechanisms by which adult pluripotent stem cells (APSCs) are formed and maintained in highly regenerative animal species. The key objectives are to: (1) determine the molecular trajectory of APSC formation, (2) define the chromatin landscape...
This Project Grant award of $651,596 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research at Cold Spring Harbor Laboratory (CSHL) to investigate the molecular mechanisms that coordinate gene expression, cell fate determination, and tissue growth during development. The key products and services to be delivered include: 1) Determining the molecular structures and dynamics of protein-protein and...
This $1,737,000 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development of innovative single-cell genomics technologies for joint analysis of regulatory dynamics and transcriptional states. Key objectives include: Developing multiomics tools to measure rates of epigenomic changes (DNA methylation, demethylation, oxidative damage, DNA repair) and relate these to...
This $1,000,000 four-year Project Grant from the National Science Foundation's (NSF) Biological Sciences program (CFDA 47.074) will fund research at Northeastern University exploring the role of mitochondria in regulating cell fate decisions during early mammalian development. Specifically, the researchers will test the hypothesis that differential allocation of mitochondrial subtypes, which vary in biochemical properties and protein content including levels of the transcription factor TEAD4,...
The National Institute of General Medical Sciences (NIGMS) awarded a $148,568 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to President and Fellows of Harvard College (Harvard University) for a 1-year project period from August 1, 2024 to July 31, 2025. The grant will fund research to elucidate the regulatory mechanisms and functional role of the MEST-COPG2 imprinted domain, which is associated with developmental and postnatal growth defects as well as atypical...
This $777,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) is funding a research project at the University of Washington to understand the cellular mechanisms that regulate mitochondrial DNA (mtDNA) heteroplasmy and its relationship to mitochondrial quality control pathways. The key objectives are: 1) using single-cell sequencing to test hypotheses about how mitochondrial quality control...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $162,874 to The Trustees of Princeton University to conduct research on the regulation of protein dynamics in the ectoderm germ layer of Drosophila embryos. The research aims to quantify protein dynamics and post-transcriptional regulation during cell differentiation and embryonic development using genetically...
The National Institute of General Medical Sciences (NIGMS) awarded Oregon State University a $1,048,663 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859). The award, which runs from August 1, 2024 to May 31, 2029, aims to improve the understanding of factors underlying common trait variation in real populations. The project will incorporate molecular phenotyping and metabolomics into the experimental evolution framework to study differences in rates of...
This federal Project Grant award of $372,588 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research at The Ohio State University to investigate the "metabolic clock" that regulates cell fate decisions. The research aims to unveil the molecular mechanisms by which signals control cell life and death outcomes, with a focus on understanding how metabolic processes and mitochondrial dynamics...
The National Institute of General Medical Sciences (NIGMS) awarded a $421,600 Project Grant (CFDA 93.859) to the Morgridge Institute for Research, Inc. in Madison, Wisconsin to support a 5-year research program focused on understanding the interplay of genetic and environmental factors that influence human cell fitness. The key research objectives include: 1) elucidating context-dependent genetic contributions to cell growth, 2) examining physiologic nutrient dependencies, and 3) delineating...

This $578,254 federal Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports a research project to investigate the role of mitochondrial metabolism in regulating species-specific developmental rates across mammals. The project leverages an in vitro system to quantify differences in developmental speed between mouse and human cells, with the goal of uncovering the mechanisms that control the wide variation in embryonic development duration observed across species. A key sub-award to Harvard Medical School will contribute bioinformatic analyses of subcellular mRNA dynamics to the project. The research aims to uncover strategies for manipulating developmental speed, with potential applications in enhancing human stem cell differentiation and limiting cancer cell proliferation. The project is expected to run from Sep 1, 2024 to Jun 30, 2029.

Generated 6/10/25, 3:35 AM